JACQUELYN O'DONNELL: Open Payments
NPI 1518402767 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,503 in 74 payments from 15 companies in 2025. Trend: 2023 $715 · 2024 $2,179 · 2025 $1,503
Food & beverage: $1,503
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $437 |
| ABBVIE INC. | 18 | $331 |
| UCB, Inc. | 13 | $210 |
| Regeneron Healthcare Solutions, Inc. | 13 | $185 |
| Galderma Laboratories, L.P. | 3 | $54 |
| Lilly USA, LLC | 2 | $53 |
| Incyte Corporation | 3 | $53 |
| PFIZER INC. | 2 | $45 |
| Janssen Biotech, Inc. | 1 | $27 |
| LNHC, Inc | 1 | $25 |
Products named: DUPIXENT, RINVOQ, Bimzelx, NEMLUVIO, TALTZ, OPZELURA, SKYRIZI, CIBINQO.
Industry payments across IN — which companies pay providers there.
